Priming of human CD4+ antigen-specific T cells to undergo apoptosis by HIV-infected monocytes: A two-step mechanism involving the gp120 molecule

Journal of Clinical Investigation

Volumn 99, Issue 2, 1997, Pages 257-266

  Cottrez, Françoise ^a   Manca, Fabrizio ^b   Dalgleish, Angus G ^c   Arenzana Seisdedos, Fernando ^d   Capron, André ^a   Groux, Hervé ^a,e  

^a INSTITUT PASTEUR DE LILLE   (France)

^b UNIVERSITY OF GENOA   (Italy)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d INSTITUT PASTEUR   (France)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

apoptosis; gp120; human immunodeficiency virus; monocytes; T cells

Indexed keywords

CD4 ANTIGEN; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CHIMPANZEE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0031030302     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119154     Document Type: Article

References (57)

1. Fauci, A.S. 1988. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science (Wash. DC). 239:617-622.
2. Harper, M.E., L.M. Marselle, R.C. Gallo, and F. Wong-Staal. 1986. Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc. Natl. Acad. Sci. USA. 83:772-776.
3. Schnittman, S.M., M.C. Psallidopoulos, H.C. Lane, L. Thompson, M. Baseler, F. Massari, C.H. Fox, N.P. Salzman, and A.S. Fauci. 1989. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science (Wash. DC). 245:305-308.
4. Brinchmann, I.E., J. Albert, and F. Vartdal. 1991. Few infected CD4+ T cells but a high proportion of replication-competent provirus copies in asymptomatic human immunodeficiency virus type 1 infection. J. Virol. 65:2019-2023.
5. Miedema, F., A.J. Petit, F.G. Terpstra, J.K. Schattenkerk, F. de Wolf, B.J. Al, M. Roos, J.M. Lange, S.A. Danner, J. Goudsmit, et al. 1988. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J. Clin. Invest. 82:1908-1914.
6. Clerici, M., N.I. Stocks, R.A. Zajac, R.N. Boswell, D.R. Lucey, C.S. Via, and G.M. Shearer. 1989. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J. Clin. Invest. 84:1892-1899.
7. Groux, H., G. Torpier, D. Monte, Y. Mouton, A. Capron, and J.C. Ameisen. 1992. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175:331-340.
8. Gougeon, M.L., S. Garcia, J. Heeney, R. Tschopp, H. Lecoeur, D. Guetard, V. Rame, C. Dauguet, and L. Montagnier. 1993. Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res. Hum. Retroviruses. 9:553-563.
9. Meyaard, L., S.A. Otto, R.R. Jonker, M.J. Mijnster, R.P. Keet, and F. Miedema. 1992. Programmed death of T cells in HIV-1 infection. Science (Wash. DC). 257:217-219.
10. Newell, M.K., L.J. Haughn, C.R. Maroun, and M.H. Julius. 1990. Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen. Nature (Lond.). 347:286-289.
11. Banda, N.K., J. Bernier, D.K. Kurahara, R. Kurrle, N. Haigwood, R.P. Sekaly, and T.H. Finkel. 1992. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J. Exp. Med. 176: 1099-1106.
12. Ameisen, J.C., and A. Capron. 1991. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol. Today. 12:102-105.
13. Li, C.J., D.J. Friedman, C. Wang, V. Metelev, and A.B. Pardee. 1995. Induction of apoptosis in uninfected lymphocytes by HIV-1 tat protein. Science (Wash. DC). 268:429-431.
14. Weinhold, K.J., H.K. Lyerly, S.D. Stanley, A.A. Austin, T.J. Matthews, and D.P. Bolognesi. 1989. HIV-1 gp120-mediated immune suppression and lymphocyte destruction in the absence of viral infection. J. Immunol. 142:3091-3097.
15. Terai, C., R.S. Kornbluth, C.D. Pauza, D.D. Richman, and D.A. Carson. 1991. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J. Clin. Invest. 87:1710-1715.
16. Mittler, R.S., and M.K. Hoffmann. 1989. Synergism between HIV gp120 and gp120-specific antibody in blocking human T cell activation. Science (Wash. DC). 245:1380-1382.
17. Groux, H., D. Monte, B. Plouvier, A. Capron, and J.C. Ameisen. 1993. CD3-mediated apoptosis of human medullary thymocytes and activated peripheral T cells: respective roles of interleukin-1, interleukin-2, interferon-gamma and accessory cells. Eur. J. Immunol. 23:1623-1629.
18. Estaquier, J., T. Idziorek, F. de Bels, F. Barre-Sinoussi, B. Hurtrel, A.M. Aubertin, A. Venet, M. Mehtali, E. Muchmore, P. Michel, et al. 1994. Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc. Natl. Acad. Sci. USA. 91: 9431-9435.
19. Meyaard, L., S.A. Otto, I.P. Keet, M.T. Roos, and F. Miedema. 1994. Programmed death of T cells in human immunodeficiency virus infection. No correlation with progression to disease. J. Clin. Invest. 93:982-988.
20. Pantaleo, G., C. Graziosi, L. Butini, P.A. Pizzo, S.M. Schnittman, D.P. Kotler, and A.S. Fauci. 1991. Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 88:9838-9842.
21. Fox, C.H., K. Tenner-Racz, P. Racz, A. Firpo, P.A. Pizzo, and A.S. Fauci. 1991. Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA [published erratum appears in J. Infect. Dis. 1992 Jun; 165(6):1161]. J. Infect. Dis. 164:1051-1057.
22. Spiegel, H., H. Herbst, G. Niedobitek, H.D. Foss, and H. Stein. 1992. Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells. Am. J. Pathol. 140:15-22.
23. Meltzer, M.S., D.R. Skillman, D.L. Hoover, B.D. Hanson, J.A. Turpin, D.C. Kalter, and H.E. Gendelman. 1990. Macrophages and the human immunodeficiency virus. Immunol. Today. 11:217-223.
24. Schuitemaker, H., L. Meyaard, N.A. Kootstra, R. Dubbes, S.A. Otto, M. Tersmette, J.L. Heeney, and F. Miedema. 1993. Lack of T cell dysfunction and programmed cell death in human immunodeficiency virus type 1-infected chimpanzees correlates with absence of monocytotropic variants. J. Infect. Dis. 168:1140-1147.
25. Manca, F., L. Walker, A. Newell, F. Celada, J.A. Habeshaw, and A.G. Dalgleish. 1992. Inhibitory activity of HIV envelope gp120 dominates over its antigenicity for human T cells. Clin. Exp. Immunol. 88:17-22.
26. Manca, F., J.A. Habeshaw, and A.G. Dalgleish. 1990. HIV envelope glycoprotein, antigen specific T-cell responses, and soluble CD4. Lancet. 335:811-815.
27. Monte, D., H. Groux, B. Raharinivo, B. Plouvier, J. Dewulf, T. Clavel, C. Grangette, G. Torpier, C. Auriault, A. Capron, et al. 1992. Productive human immunodeficiency virus-1 infection of megakaryocytic cells is enhanced by tumor necrosis factor-alpha. Blood. 79:2670-2679.
28. Ormerod, M.G., M.K. Collins, G. Rodriguez-Tarduchy, and D. Robertson. 1992. Apoptosis in interleukin-3-dependent haemopoietic cells. Quantification by two flow cytometric methods. J. Immunol. Methods. 153:57-65.
29. Cottrez, F., C. Auriault, A. Capron, and H. Groux. 1994. Quantitative PCR: validation of the use of a multispecific internal control. Nucleic. Acids. Res. 22:2712-2713.
30. Millman, G. 1991. Radioisotope and nonradioisotope detection of HIV PCR products from infected and uninfected individuals. In Viral Quantification in HIV Infection. J.M. Andrieu, editor. John Libbey Eurotext, Paris. 121-131.
31. Meyerhans, A., R. Cheynier, J. Albert, M. Seth, S. Kwok, J. Sninsky, L. Morfeldt-Manson, B. Asjo, and S. Wain-Hobson. 1989. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell. 58:901-910.
32. Poznansky, M.C., B. Walker, W.A. Haseltine, J. Sodroski, and E. Langhoff. 1991. A rapid method for quantitating the frequency of peripheral blood cells containing HIV-1 DNA. J. Acquired Immune Defic. Syndr. 4:368-373.
33. Ho, D.D., T. Moudgil, and M. Alam. 1989. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N. Engl. J. Med. 321:1621-1625.
34. + T cells. AIDS Res. Hum. Retroviruses. 10:523-527.
35. Adachi, A., H.E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M.A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
36. Mann, D.L., S. Gartner, F. Le Sane, H. Buchow, and M. Popovic. 1990. HIV-1 transmission and function of virus-infected monocytes/macrophages. J. Immunol. 144:2152-2158.
37. Laurent-Crawford, A.G., B. Krust, S. Muller, Y. Riviere, M.A. Rey-Cuille, J.M. Bechet, L. Montagnier, and A.G. Hovanessian. 1991. The cytopathic effect of HIV is associated with apoptosis. Virology. 185:829-839.
38. Dayton, A.I., J.G. Sodroski, C.A. Rosen, W.C. Goh, and W.A. Haseltine. 1986. The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell. 44:941-947.
39. Fisher, A.G., M.B. Feinberg, S.F. Josephs, M.E. Harper, L.M. Marselle, G. Reyes, M.A. Gonda, A. Aldovini, C. Debouk, R.C. Gallo, et al. 1986. The trans-activator gene of HTLV-III is essential for virus replication. Nature (Lond.). 320:367-371.
40. Westendorp, M.O., R. Frank, C. Ochsenbauer, K. Stricker, J. Dhein, H. Walczak, K.M. Debatin, and P.H. Krammer. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature (Lond.). 375:497-500.
41. Viscidi, R.P., K. Mayur, H.M. Lederman, and A.D. Frankel. 1989. Inhibition of antigen-specific lymphocyte proliferation by tat protein of HIV-1. Science (Wash. DC). 246:263-274.
42. Purvis, S.F., D.L. Georges, T.M. Williams, and M.M. Lederman. 1990. Suppression of interleukin-2 and interleukin-2 receptor expression in Jurkat cells stably expressing the HIV tat protein. Cell. Immunol. 144:32-42.
43. Meyaard, L., S.A. Otto, H. Schuitemaker, and F. Miedema. 1992. Effects of HIV-1 Tat protein on human T cell proliferation. Eur. J. Immunol. 22: 2729-2732.
44. Caputo, A., J.G. Sodroski, and W.A. Haseltine. 1990. Constitutive expression of HIV-1 tat protein in human Jurkat T cells using a BK virus vector. J. Acquired Immune Defic. Syndr. 3:372-379.
45. Zauli, G., D. Gibellini, D. Milani, M. Mazzoni, P. Borgatti, M. La Placa, and S. Capitani. 1993. Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis. Cancer Res. 53:4481-4485.
46. Macatonia, S.E., R. Lau, S. Patterson, A.J. Pinching, and S.C. Knight. 1990. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology. 71:38-45.
47. Goldman, F., W.A. Jensen, G.L. Johnson, L. Heasley, and J.C. Cambier. 1994. gp120 ligation of CD4 induces p561ck activation and TCR desensitization independent of TCR tyrosine phosphorylation. J. Immunol. 153:2905-2917.
48. Hubert, P., G. Bismuth, M. Korner, and P. Debre. 1995. HIV-1 glycoprotein gp120 disrupts CD4-p561ck/CD3-T cell receptor interactions and inhibits CD3 signaling. Eur. J. Immunol. 25:1417-1425.
49. Nara, P., W. Hatch, J. Kessler, J. Kelliher, and S. Carter. 1989. The biology of human immunodeficiency virus-1 IIIB infection in the chimpanzee: in vivo and in vitro correlations. J. Med. Primatol. 18:343-355.
50. Fultz, P.M., H.M. McClure, R.B. Swenson, C.R. McGrath, A. Brodie, J.P. Getchell, F.C. Jensen, D.C. Anderson, J.R. Broderson, and D.P. Francis. 1986. Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome. J. Virol. 58:116-124.
51. Nara, P.L., L. Smit, N. Dunlop, W. Hatch, M. Merges, D. Waters, J. Kelliher, R.C. Gallo, P.J. Fischinger, and J. Goudsmit. 1990. Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees. J. Virol. 64: 3779-3791.
52. Gendelman, H.E., G.D. Ehrlich, L.M. Baca, S. Conley, J. Ribas, D.C. Kalter, M.S. Meltzer, B.J. Poiesz, and P. Nara. 1991. The inability of human immunodeficiency virus to infect chimpanzee monocytes can be overcome by serial viral passage in vivo. J. Virol. 65:3853-3863.
53. Watanabe, M., D.J. Ringler, P.N. Fultz, J.J. MacKey, J.E. Boyson, C.G. Levine, and N.L. Letvin. 1991. A chimpanzee-passaged human immunodeficiency virus isolate is cytopathic for chimpanzee cells but does not induce disease. J. Virol. 65:3344-3348.
54. Desrosiers, R.C., A. Hansen-Moosa, K. Mori, D.P. Bouvier, N.W. King, M.D. Daniel, and D.J. Ringler. 1991. Macrophage-tropic variants of SIV are associated with specific AIDS-related lesions but are not essential for the development of AIDS. Am J. Pathol. 139:29-35.
55. van Noesel, C.J., R.A. Gruters, F.G. Terpstra, P.T. Schellekens, R.A. van Lier, and F. Miedema. 1990. Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men. J. Clin. Invest. 86:293-299.
56. Converse, P.J., T.E. Fehniger, A. Ehrnst, O. Strannegard, and S. Britton. 1990. Immune responses to fractionated cytomegalovirus (CMV) antigens after HIV infection. Loss of cellular and humoral reactivity to antigens recognized by HIV-, CMV+ individuals. Clin. Exp. Immunol. 82:559-566.
57. Levine, B.L., J.D. Mosca, J.L. Riley, R.G. Carrol, M.T. Vahey, L.L. Jagodzinski, K.F. Wagner, D.L. Mayers, D.S. Burke, O.S. Weislow, et al. 1996. Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation. Nature (Lond.). 272:1939-1943.